HIROKO NGUYEN: Open Payments
NPI 1356649669 · RICHMOND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$200 in 5 payments from 3 companies in 2025. Trend: 2023 $469 · 2024 $329 · 2025 $200
Food & beverage: $200
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $91 |
| Madrigal Pharmaceuticals | 2 | $90 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: REZDIFFRA, TRELEGY ELLIPTA.
Industry payments across TX — which companies pay providers there.
